We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.68B
AUM Growth
+$43.8M
Cap. Flow
-$77.1M
Cap. Flow %
-2.88%
Top 10 Hldgs %
33.94%
Holding
121
New
7
Increased
28
Reduced
73
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$19.5M
2
CORT icon
Corcept Therapeutics
CORT
+$15.5M
3
GTLS
Chart Industries
GTLS
+$14M
4
TGTX icon
TG Therapeutics
TGTX
+$12.7M
5
EHC icon
Encompass Health
EHC
+$10.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.9M
2
APP icon
Applovin
APP
+$23.4M
3
UBER icon
Uber
UBER
+$22.7M
4
IQV icon
IQVIA
IQV
+$11.8M
5
VRT icon
Vertiv
VRT
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 29.33%
2 Financials 13.75%
3 Communication Services 12.62%
4 Consumer Discretionary 10.61%
5 Healthcare 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAS icon
101
Cintas
CTAS
$81.3B
$882K 0.03%
4,828
– –
GPN icon
102
Global Payments
GPN
$22.8B
$852K 0.03%
7,600
-5,080
-40% -$556K
ATO icon
103
Atmos Energy
ATO
$28.8B
$704K 0.03%
5,057
– –
RSP icon
104
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$579K 0.02%
3,306
-95
-3% -$17.2K
XLF icon
105
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$577K 0.02%
11,932
+215
+2% +$10.4K
IWF icon
106
iShares Russell 1000 Growth ETF
IWF
$128B
$494K 0.02%
4,916
-168
-3% -$16.5K
JNJ icon
107
Johnson & Johnson
JNJ
$625B
$373K 0.01%
2,580
– –
XLK icon
108
State Street Technology Select Sector SPDR ETF
XLK
$123B
$282K 0.01%
2,424
-244
-9% -$28.4K
VONV icon
109
Vanguard Russell 1000 Value ETF
VONV
$22B
$250K 0.01%
3,078
-1,367
-31% -$115K
LAMR icon
110
Lamar Advertising Co
LAMR
$16.3B
$245K 0.01%
2,015
-110
-5% -$14.4K
XLU icon
111
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
$241K 0.01%
6,372
– –
IWD icon
112
iShares Russell 1000 Value ETF
IWD
$83.9B
$225K 0.01%
1,214
-2
-0.2% -$384
XLY icon
113
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
$221K 0.01%
+1,966
New +$210K
VO icon
114
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$206K 0.01%
3,120
– –
CVX icon
115
Chevron
CVX
$366B
– –
-59,453
Closed -$8.76M
FDX icon
116
FedEx
FDX
$75.4B
– –
-14,639
Closed -$4.01M
IQV icon
117
IQVIA
IQV
$39.3B
– –
-49,964
Closed -$11.8M
MRK icon
118
Merck
MRK
$318B
– –
-218,985
Closed -$24.9M
LBPH
119
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
– –
-299,156
Closed -$9.97M
1 2 3 4
5

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
KCM
Kedalion Capital Management London, United Kingdom $3.48B AUM 17.74% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return

Braun Stacey Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Braun Stacey Associates held 121 positions worth $2.68B, up 1.7% from $2.63B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q4 2024 filing shows 7 new, 28 increased, 73 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 348,518 shares worth $19.7M. The largest sale was Merck, an estimated $24.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q4 2024 buy was Bristol-Myers Squibb: 348,518 shares worth $19.7M.
  • Braun Stacey Associates added most to Targa Resources in Q4 2024, an estimated $10.2M increase.
  • Braun Stacey Associates's biggest Q4 2024 reduction was Applovin, cutting an estimated $23.4M.
  • Braun Stacey Associates fully exited Merck in Q4 2024, selling an estimated $24.9M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.68B portfolio in Q4 2024.
  • Braun Stacey Associates opened 7 new positions and closed 5 in Q4 2024.
  • Braun Stacey Associates's portfolio value rose 1.7% quarter-over-quarter to $2.68B.

Based on Braun Stacey Associates's 13F filing for Q4 2024, filed 31 Jan 2025.